<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00411112</url>
  </required_header>
  <id_info>
    <org_study_id>3737</org_study_id>
    <nct_id>NCT00411112</nct_id>
  </id_info>
  <brief_title>Sentinel Node in Colon Cancer</brief_title>
  <official_title>Sentinel Node Study in Colon Cancer Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <brief_summary>
    <textblock>
      More than 20% of patients operated on for colon cancer without node metastasis will develop
      visceral metastases. The purpose of the study is to determine sentinel lymph nodes with two
      methods: blue injection and isotopic detection. Sentinel nodes will then be analyzed by
      immunohistochemy to detect micrometastases. No adjuvant therapy will be proposed to the
      patient if there are only node's micrometastases and survival will be analyzed in regard to
      the presence of these micrometastasis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2007</start_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival without recurrence after 3 years</measure>
  </primary_outcome>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Colon Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blue and isotopic detection of sentinel lymph nodes</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult

          -  colon cancer

          -  open surgery

        Exclusion Criteria:

          -  emergency surgery

          -  metastases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cécile Brigand, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cécile Brigand, MD</last_name>
    <phone>3 33 88 12 72 36</phone>
    <email>cecile.brigand@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de Chirurgie Générale et Digestive - Hôpital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile Brigand, MD</last_name>
      <phone>33.3.88.12.72.36</phone>
      <email>cecile.brigand@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Christian Meyer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Serge Rohr, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cécile Brigand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2006</study_first_submitted>
  <study_first_submitted_qc>December 12, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2006</study_first_posted>
  <last_update_submitted>January 9, 2009</last_update_submitted>
  <last_update_submitted_qc>January 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2009</last_update_posted>
  <keyword>Sentinel node</keyword>
  <keyword>Isosulphan blue</keyword>
  <keyword>Isotopic detection</keyword>
  <keyword>Survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

